Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T P Davis

Showing results (21-30 of 172) with videos related to

Pageof 18
Sort By:
Proceedings of the Western Pharmacology Society|January 1, 1984
The pro-enkephalin A derivative, peptide E, is centrally processed to active fragmentsT P Davis, F Porreca, A Dray
Progress in Cardiovascular Diseases|November 1, 1993
Electrocardiographic changes associated with acute cerebrovascular disease: a clinical reviewT P Davis, J Alexander, M Lesch
Peptides|May 1, 1984
Endorphins and the central inhibition of urinary bladder motilityA Dray, R Metsch, T P Davis
The American Journal of Physiology|March 1, 1990
Inhibition of intestinal degradation of somatostatin by rat milkR K Rao, O Koldovsky, T P Davis
Peptides|November 1, 1993
Fate of intraduodenally administered somatostatin in rats in vivoR K Rao, O Koldovsky, T P Davis
Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology|January 1, 1986
Central metabolism of beta-endorphin in different species of temperature acclimated rodentsT P Davis, A Han, M K Yousef
European Journal of Pharmacology|April 20, 1984
Centrally acting drugs alter in vitro beta-endorphin processing in the ratT P Davis, H Schoemaker, A J Culling
Peptides|July 1, 1989
Peptide fragments derived from the beta-chain of hemoglobin (hemorphins) are centrally active in vivoT P Davis, T J Gillespie, F Porreca
Life Sciences|July 27, 1981
High performance liquid chromatography of a new anticancer drug, ADCA--physicochemical properties and pharmacokineticsY M Peng, T P Davis, D S Alberts
Peptides|November 1, 1992
Permeability of the blood-brain barrier to peptides: an approach to the development of therapeutically useful analogsW A Banks, K L Audus, T P Davis
Pageof 18

Showing results (21-30 of 172) with videos related to

Sort By:
Pageof 18
Proceedings of the Western Pharmacology Society|January 1, 1984
The pro-enkephalin A derivative, peptide E, is centrally processed to active fragmentsT P Davis, F Porreca, A Dray
Progress in Cardiovascular Diseases|November 1, 1993
Electrocardiographic changes associated with acute cerebrovascular disease: a clinical reviewT P Davis, J Alexander, M Lesch
Peptides|May 1, 1984
Endorphins and the central inhibition of urinary bladder motilityA Dray, R Metsch, T P Davis
The American Journal of Physiology|March 1, 1990
Inhibition of intestinal degradation of somatostatin by rat milkR K Rao, O Koldovsky, T P Davis
Peptides|November 1, 1993
Fate of intraduodenally administered somatostatin in rats in vivoR K Rao, O Koldovsky, T P Davis
Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology|January 1, 1986
Central metabolism of beta-endorphin in different species of temperature acclimated rodentsT P Davis, A Han, M K Yousef
European Journal of Pharmacology|April 20, 1984
Centrally acting drugs alter in vitro beta-endorphin processing in the ratT P Davis, H Schoemaker, A J Culling
Peptides|July 1, 1989
Peptide fragments derived from the beta-chain of hemoglobin (hemorphins) are centrally active in vivoT P Davis, T J Gillespie, F Porreca
Life Sciences|July 27, 1981
High performance liquid chromatography of a new anticancer drug, ADCA--physicochemical properties and pharmacokineticsY M Peng, T P Davis, D S Alberts
Peptides|November 1, 1992
Permeability of the blood-brain barrier to peptides: an approach to the development of therapeutically useful analogsW A Banks, K L Audus, T P Davis
Pageof 18